Literature DB >> 15486012

The effects of hypoxia on the modulation of human TREK-1 potassium channels.

Alex J Caley1, Marco Gruss, Nicholas P Franks.   

Abstract

Two-pore-domain potassium channels are a family of ion channels that are widely believed to play an important role in maintaining and regulating neuronal excitability. It has been shown that they can be modulated by an extraordinarily diverse range of endogenous and exogenous factors. One particular member of the family, TREK-1 (also known as KCNK2), is activated by increasing temperature, membrane stretch and internal acidosis, but is also sensitive to the presence of certain polyunsaturated fatty acids (such as arachidonic acid), neuroprotectants (such as riluzole) and volatile and gaseous general anaesthetics (such as halothane and nitrous oxide). It has recently been reported that TREK-1 channels are also affected by oxygen concentrations, and that at the levels of hypoxia that occur in the normal human brain, the channels greatly change their properties and, for example, lose their ability to be modulated by arachidonic acid and internal acidosis. These reports seriously challenge the idea that TREK-1 is a target for general anaesthetics and neuroprotectants. However, in this report we show that TREK-1 is not oxygen sensitive, and its ability to be activated by anaesthetics, arachidonic acid and internal acidosis remains unaltered under conditions of hypoxia. We further show that the protocol used by previous workers to prepare hypoxic solutions of arachidonic acid results in the removal of the compound from solution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486012      PMCID: PMC1665483          DOI: 10.1113/jphysiol.2004.076240

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  18 in total

Review 1.  Potassium leak channels and the KCNK family of two-P-domain subunits.

Authors:  S A Goldstein; D Bockenhauer; I O'Kelly; N Zilberberg
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

Review 2.  Properties and modulation of mammalian 2P domain K+ channels.

Authors:  A J Patel; E Honoré
Journal:  Trends Neurosci       Date:  2001-06       Impact factor: 13.837

3.  The action of fluothane; a new volatile anaesthetic.

Authors:  J RAVENTOS
Journal:  Br J Pharmacol Chemother       Date:  1956-12

4.  Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones.

Authors:  U Bonnet; D Bingmann; M Wiemann
Journal:  Eur Neuropsychopharmacol       Date:  2000-03       Impact factor: 4.600

5.  Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel.

Authors:  H J Meadows; C D Benham; W Cairns; I Gloger; C Jennings; A D Medhurst; P Murdock; C G Chapman
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

6.  Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors.

Authors:  F Lesage; C Terrenoire; G Romey; M Lazdunski
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

7.  Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection.

Authors:  P Miller; P J Kemp; A Lewis; C G Chapman; H J Meadows; C Peers
Journal:  J Physiol       Date:  2003-02-28       Impact factor: 5.182

Review 8.  Pharmacology of neuronal background potassium channels.

Authors:  Florian Lesage
Journal:  Neuropharmacology       Date:  2003-01       Impact factor: 5.250

9.  Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane.

Authors:  Marco Gruss; Trevor J Bushell; Damian P Bright; William R Lieb; Alistair Mathie; Nicholas P Franks
Journal:  Mol Pharmacol       Date:  2004-02       Impact factor: 4.436

10.  Polymodal regulation of hTREK1 by pH, arachidonic acid, and hypoxia: physiological impact in acidosis and alkalosis.

Authors:  Paula Miller; Chris Peers; Paul J Kemp
Journal:  Am J Physiol Cell Physiol       Date:  2003-10-01       Impact factor: 4.249

View more
  11 in total

1.  TREK-1 currents in smooth muscle cells from pregnant human myometrium.

Authors:  Nathanael S Heyman; Chad L Cowles; Scott D Barnett; Yi-Ying Wu; Charles Cullison; Cherie A Singer; Normand Leblanc; Iain L O Buxton
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-26       Impact factor: 4.249

Review 2.  K+ channels in apoptosis.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

3.  Analyses of gating thermodynamics and effects of deletions in the mechanosensitive channel TREK-1: comparisons with structural models.

Authors:  Grigory Maksaev; Adina Milac; Andriy Anishkin; H Robert Guy; Sergei Sukharev
Journal:  Channels (Austin)       Date:  2011-01-01       Impact factor: 2.581

4.  Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1.

Authors:  Xin-cai Ji; Wan-hong Zhao; Dong-xu Cao; Qiao-qiao Shi; Xiao-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

Review 5.  The CNS under pathophysiologic attack--examining the role of K₂p channels.

Authors:  Petra Ehling; Manuela Cerina; Thomas Budde; Sven G Meuth; Stefan Bittner
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

6.  The Inhibition of TREK2 Channel by an Oxidizing Agent, 5,5'-dithio-bis (2-nitrobenzoic acid), via Interaction with the C-terminus Distal to the 353rd Amino Acid.

Authors:  Kyoung Sun Park; Hyoweon Bang; Eun-Young Shin; Chan Hyung Kim; Yangmi Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

7.  AMP-activated protein kinase inhibits TREK channels.

Authors:  Orsolya Kréneisz; Justin P Benoit; Douglas A Bayliss; Daniel K Mulkey
Journal:  J Physiol       Date:  2009-12-15       Impact factor: 5.182

8.  Behavioral characterization of mice lacking Trek channels.

Authors:  Kelsey Mirkovic; Jaime Palmersheim; Florian Lesage; Kevin Wickman
Journal:  Front Behav Neurosci       Date:  2012-09-07       Impact factor: 3.558

9.  A human TREK-1/HEK cell line: a highly efficient screening tool for drug development in neurological diseases.

Authors:  Hamid Moha ou Maati; Rémi Peyronnet; Christelle Devader; Julie Veyssiere; Fabien Labbal; Carine Gandin; Jean Mazella; Catherine Heurteaux; Marc Borsotto
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

10.  Intracellular activation of full-length human TREK-1 channel by hypoxia, high lactate, and low pH denotes polymodal integration by ischemic factors.

Authors:  Sourajit Mukherjee; Sujit Kumar Sikdar
Journal:  Pflugers Arch       Date:  2020-10-06       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.